From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
Control
Letter
Phone
Total
N = 51
N = 53
N = 155
Mean
SD
MPR (%)
70.4
31.8
79.7
27.9
78.4
26.5
76.2
28.9
Persistence (weeks)
38.6
17.5
44.7
16.8
42.8
14.8
42.1
16.5